Parallax Volatility Advisers’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Parallax Volatility Advisers’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,500	Closed	-$253K	–	3052
2023 Q1	$253K	Buy	+10,500	New	+$132K	﹤0.01%	1939
2021 Q3	–	Sell	-50,000	Closed	-$422K	–	2307
2021 Q2	$422K	Hold	50,000	–	–	﹤0.01%	1188
2021 Q1	$525K	Buy	+50,000	New	+$704K	﹤0.01%	947

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Parallax Volatility Advisers's PRVB Position: Q2 2023 in Review

Parallax Volatility Advisers sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 26,178 shares — an estimated $631K sold.

Parallax Volatility Advisers first reported a position in PRVB in Q1 2021 and held it in 7 quarters. The position peaked at $631K in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Parallax Volatility Advisers reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Parallax Volatility Advisers sold 26,178 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $631K.
Parallax Volatility Advisers first reported a position in Provention Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Parallax Volatility Advisers's Provention Bio, Inc. Common Stock position peaked at $631K in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Parallax Volatility Advisers's 13F filing for Q2 2023, filed 14 Aug 2023.